Moreover, Cooper et al. demonstrated that BRAF inhibition leads to a higher percentage of activated intratumoral CD8+ T cells that secrete IFN-γ and TNF-α in a BRAF-mutant murine melanoma model [133]. The gene discussed is BRAF; the disease is melanoma.